Steve Harr is President & CEO of Sana Biotechnology, Inc.. Currently has a direct ownership of 7.88 Million shares of SANA, which is worth approximately $16.9 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 12,820 shares (Common Stock) at a price of $2.56 per share, resulting in proceeds of $32,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.88M
0.47% 3M change
0.47% 12M change
Total Value Held $16.9 Million

Steve Harr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
SELL
Payment of exercise price or tax liability
$32,819 $2.56 p/Share
12,820 Reduced 0.16%
7,876,930 Common Stock
Mar 07 2025
BUY
Exercise of conversion of derivative security
-
50,000 Added 0.63%
7,889,750 Common Stock
Apr 14 2021
SELL
Bona fide gift
-
334,000 Reduced 4.09%
7,839,750 Common Stock
Feb 08 2021
BUY
Conversion of derivative security
-
2,031,250 Added 19.9%
8,173,750 Common Stock
SH

Steve Harr

President & CEO
Seattle, WA

Track Institutional and Insider Activities on SANA

Follow Sana Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SANA shares.

Notify only if

Insider Trading

Get notified when an Sana Biotechnology, Inc. insider buys or sells SANA shares.

Notify only if

News

Receive news related to Sana Biotechnology, Inc.

Track Activities on SANA